:::回首頁English網站導覽常見問答聯絡我們FB粉絲專頁  
本院簡介 研究單位 技術移轉 研究資源 圖書館 訊息公告 院內網站
 
::: 首頁>
* * *
*
 
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR114: a multi-targeted kinase inhibitor for solid tumors”(2018/12/13)

 Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR114: a multi-targeted kinase inhibitor for solid tumors

Date: 2018.12.13

1.         Title:

NHRI technology, “DBPR114: a multi-targeted kinase inhibitor for solid tumors” (abbreviated as “The Technology”) available for industry-academia collaboration or technology licensing.

2.         Description:

DBPR114 is a novel small molecule multi-target kinase inhibitor. Multi-target drugs can more effectively inhibit cancer cell proliferation, overcome drug resistance, and show better and broader anti-cancer effects. DBPR114 significantly shrank tumor growth of 8 different cancer cells in vivo intravenous administration. These results indicate the potential of DBPR114 as an IND candidate for various cancers, including AML, pancreatic, liver and gastric cancers, and all important cancers currently without very effective treatments.

3.         Potential collaboration partner qualifications:

(1)     be incorporated and approved by law and does not have any record of misconduct or conviction for any offense

(2)     better to have related experience and skills for developing The Technology

(3)     better to have experience of international collaboration and clinical trial

(4)     be willing to provide long-term investment

4.         Registration

Please contact to Mr. Hua-Hsuan Liang (Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, R.O.C., Tel: +88637-246166#33206, E-mail: huahsuan@nhri.org.tw).

5.         Other:

If The Technology has been exclusively licensed, this announcement will automatically invalid. For detailed status of The Technology, please contact to the case officer.

 

Attachments:

I: Announcement

II: Technology Transfer Vendor Qualification Form

III: Industry-Academia Collaboration Proposal

 

 


 

回上一層

 

*
* * *
     
  政策與免責聲明 | 財團法人國家衛生研究院版權所有
竹南院區:苗栗縣竹南鎮 35053 科研路35號 -- 電話: +886-37-206-166
台北辦事處:台北市南港區 11503 園區街3號10樓(南港軟體園區F棟) -- 電話: +886-2-2653-4401
台南院區:台南市北區 70456 勝利路367號(統一健康研究大樓) -- 電話: +886-6-700-0123
各單位分機代表號
電子信箱:webmaster@nhri.org.tw
FB粉絲專頁:財團法人國家衛生研究院@NHRI.TW